Steven Pai, PhD

TitlePostdoctoral Scholar
InstitutionUniversity of California San Francisco
Address513 Parnassus Ave, Med Sci
San Francisco CA 94122
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, DavisPh.D.2015Cancer Immunobiology
    National Taiwan University M.S.2009Cancer Immunology
    National Taiwan UniversityD.V.M.2006School of Veterinary Medicine

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Faculty Mentoring

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Wang D, Quiros J, Mahuron K, Pai S, Ranzani V, Young A, Silveria S, Harwin T, Abnousian A, Pagani M, Rosenblum MD, Van Gool F, Fong L, Bluestone JA, DuPage M. Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity. Cell Rep. 2018 Jun 12; 23(11):3262-3274. PMID: 29898397.
      View in: PubMed
    2. Pai S, Khuat LT, Chen M, Murphy WJ, Abedi M. Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in Mice. Biol Blood Marrow Transplant. 2017 Jan; 23(1):30-37. PMID: 27815049.
      View in: PubMed
    3. Stolfi JL, Pai S, Murphy WJ. Preclinical modeling of hematopoietic stem cell transplantation - advantages and limitations. FEBS J. 2016 05; 283(9):1595-606. PMID: 26640088.
      View in: PubMed
    4. Mall C, Sckisel GD, Proia DA, Mirsoian A, Grossenbacher SK, Pai S, Chen M, Monjazeb AM, Kelly K, Blazar BR, Murphy WJ. Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer. Oncoimmunology. 2016 Feb; 5(2):e1075114. PMID: 27057446.
      View in: PubMed
    5. Mirsoian A, Bouchlaka MN, Sckisel GD, Chen M, Pai S, Maverakis E, Spencer RG, Fishbein KW, Siddiqui S, Monjazeb AM, Martin B, Maudsley S, Hesdorffer C, Ferrucci L, Longo DL, Blazar BR, Wiltrout RH, Taub DD, Murphy WJ. Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice. J Exp Med. 2014 Nov 17; 211(12):2373-83. PMID: 25366964; PMCID: PMC4235633.
    6. Pai S, Hsiao HH, Sun K, Chen M, Hagino T, Tellez J, Mall C, Blazar BR, Monjazeb A, Abedi M, Murphy WJ. Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels. Biol Blood Marrow Transplant. 2014 Dec; 20(12):1899-904. PMID: 25064746; PMCID: PMC4254314.
    7. Pai S, Chen M, Mirsoian A, Grossenbacher SK, Tellez J, Ames E, Sun K, Jagdeo J, Blazar BR, Murphy WJ, Abedi M. Treatment of chronic graft-versus-host disease with bortezomib. Blood. 2014 Sep 04; 124(10):1677-88. PMID: 25009225; PMCID: PMC4155274.
    8. Sun K, Hsiao HH, Li M, Ames E, Bouchlaka M, Welniak LA, Hagino T, Jagdeo J, Pai S, Chen M, Blazar BR, Abedi M, Murphy WJ. IFN-? receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation. J Immunol. 2012 Aug 15; 189(4):2033-42. PMID: 22778394; PMCID: PMC3509544.
    9. Pai S, Kuo TF, Mao SJ, Chuang TF, Lin CS, Chu RM. Immunopathogenic behaviors of canine transmissible venereal tumor in dogs following an immunotherapy using dendritic/tumor cell hybrid. Vet Immunol Immunopathol. 2011 Feb 15; 139(2-4):187-99. PMID: 21051091.
      View in: PubMed
    10. Lin CY, Chuang TF, Liao KW, Huang YJ, Pai S, Chu RM. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity. Cancer Lett. 2008 Dec 18; 272(2):285-95. PMID: 18760876.
      View in: PubMed